窪蹋勛圖厙

Skip to content

Must-Reads Of The Week From Brianna Labuskes

Hello! Its been a tough week, friends, so I wont say Happy Friday as I usually do. But I will say it is Friday, and I hope youre getting a chance to exhale. As many people informed us on social media, Shakespeare wrote King Lear under quarantine, but King Lear isnt his best, anyway, and he probably didnt have to deal with screaming stir-crazy kiddos or a constant barrage of news. If youve been staring at the wall instead of writing the next great historical play, .

On that note, though, Im going to do my very best to give you a quick look at what happened, is happening or could happen with the coronavirus outbreak (with the caveat that it would be impossible to capture the scope of this particular universe).

First, two resources that are very cool: 1) KHNs map that shows how many ICU beds there are in each county, and 2) and running tally of confirmed cases.

So here we go with the news:

Congress has been working with the administration, namely Treasury Secretary Steve Mnuchin, to put together a package that would help Americans battered economically by the shutdowns. At the core? Sending checks directly to Americans. The amount taxpayers would get, , would be tied to income and number of children. It would also create a $300 billion pot for small businesses and .

The price tag on the plan $1 trillion sounds huge, but it’s not enough to make anything but a minor dent. Congress should be thinking more in the $2 trillion-$3 trillion range.

President Donald Trump is with sending checks to Americans, a move similar to what happened during the Great Recession.

While we’re on Capitol Hill news, Sens. Richard Burr (R-N.C.) and Kelly Loeffler (R-Ga.) in February even as they were reassuring the public that the threat was well in hand. Burr, the chairman of the Senate Intelligence Committee, also three weeks ago about the potential economic impact of the outbreak. One of the stock purchases Loeffler made was in a technology company that .


Something that’s become abundantly clear over the past week is how ill-equipped the country’s health system is to bear the extra weight of a pandemic. Although Trump invoked this week, he seems . (And much of the government’s potential resources .) He also shifted the to figure out medical device and protective gear shortages. The federal governments not supposed to be out there buying vast amounts of items and then shipping, Trump said. You know, were not a shipping clerk.

Meanwhile, doctors and other health care workers are having to reuse masks, repurpose bandannas and scarves, and take other measures as some hospitals are going through five- to six-months’ worth of supplies in a week. The number of cases is expected to climb across the country and providers are turning to social media to plead for more masks and protective gear. was just one of a flood of quotes from desperate workers.

And protective gear isn’t the only thing that could run out . The (!) are taking measures to try to address the potential crisis, but hospitals are still preparing to have to make tough about whom to treat.


Although testing in the United States has ramped up, frustration over the especially since it appears that were able to get tested where others weren’t. South Korea, which identified its first case the same day the U.S. did, serves as a stark contrast. Well over 290,000 people have been tested and over 8,000 infections have been identified in that country, which is also a democracy. .


Yours truly was one of those poor, misguided souls who decided last weekend that watching Contagion was exactly what I needed in the midst of our real-life pandemic. (I immediately regretted the decision, don’t worry.) But in the movie, a scientist tests a vaccine on herself and then boom! it’s out in the world.

That’s not how , as we all know, but for many, it’s hard not to hold out hope for a quick miracle cure either through a vaccine or a treatment.

This week, Trump called chloroquine as a potential game changer. But FDA Commissioner Stephen Hahn , saying clinical trials would be needed to test its efficacy. (For a history of how chloroquine popped up on people’s radar, check out this .)

Meanwhile, the only company in the U.S. that makes chloroquine raised the price by almost 100% in January. The company has since reduced the cost.

For a glance at the status of drug and vaccine research, check out .


Many scientists and other experts are grappling with a lot of unanswerable questions, such as: Will the and how long will ? Research is emerging every day on the virus, though, such as a new death rate out of Wuhan, China, that is .


It would be impossible to highlight all the compelling stories that ran this week, so here’s an overview of ones that might make good weekend reads:


That’s it from me. And before any Shakespeare fans come for my throat, I was just joking! (Though I do prefer his comedies.) Have a safe and restful weekend.

Related Topics

COVID-19 Global Health Watch Public Health